Cameron Durrant
Chief Executive Officer chez HUMANIGEN, INC.
Fortune : - $ au 31/03/2024
Profil
Cameron Durrant is the founder of PediatRx, Inc. (2010), Quint Media, Inc. (2005), and Taran Pharma Ltd.
(2014).
He held the titles of Chief Executive & Financial Officer & Director at PediatRx, Inc. from 2010 to 2012, Chairman, President, CEO, CFO & Treasurer at Quint Media, Inc. from 2012 to 2013, and Director at Taran Pharma Ltd.
from 2014 to 2016.
Dr. Durrant is also the founder of Prism Pharmaceuticals, Inc. Dr. Durrant's current job(s) include Chairman, CAO, Chief Executive & Financial Officer at Humanigen, Inc. since 2016, Director at Alcyone Therapeutics, Inc., Director at Bexion Pharmaceuticals, Inc. since 2013, Director at Pressure Point, Inc., and Member at Royal College of General Practitioners.
Dr. Durrant's former job(s) include President & Chief Executive Officer at Spherics, Inc. from 2006 to 2007, President & Chief Executive Officer at Striker Energy Corp.
in 2010, President & Chief Executive Officer at PediaMed Pharmaceuticals, Inc. from 2003 to 2006, President & Chief Executive Officer at E.
Claiborne Robins Co., Inc. from 2012 to 2014, President & Chief Executive Officer at ECR Pharmaceuticals Co., Inc. from 2012 to 2014, Executive Chairman at Anavex Life Sciences Corp.
from 2007 to 2011, Director at Topaz Pharmaceuticals, Inc., Director at PDS Operating Corp., Independent Director at Immune Pharmaceuticals, Inc. from 2014 to 2018, Director at Reliefband Technologies LLC, and VP-Worldwide Global Strategic Marketing at Johnson & Johnson in 2009.
Dr. Durrant's education history includes an MBA from Henley Management College and a doctorate from Cardiff University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HUMANIGEN INC
-.--% | 11/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Cameron Durrant
| Sociétés | Poste | Début |
|---|---|---|
| HUMANIGEN, INC. | Chief Executive Officer | 01/03/2016 |
Alcyone Therapeutics, Inc.
 Alcyone Therapeutics, Inc. Medical SpecialtiesHealth Technology Alcyone Therapeutics, Inc. develops novel treatment modalities for difficult neurological conditions. The company was founded by Paramjith Anand, Adam S. Fleisher, Corey M. McCann, and William L. Olbricht in 2010 and is headquartered in Lowell, MA. | Director/Board Member | - |
Pressure Point, Inc.
 Pressure Point, Inc. Medical/Nursing ServicesHealth Services Pressure Point, Inc. provides health care services. The private company is based in Central Point, OR. | Director/Board Member | - |
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Director/Board Member | 30/12/2010 |
Royal College of General Practitioners
 Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Corporate Officer/Principal | 30/12/2010 |
Anciens postes connus de Cameron Durrant
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNE PHARMACEUTICALS, INC. | Director/Board Member | 10/09/2018 |
| Taran Pharma Ltd. | Founder | 01/01/2016 |
| ECR Pharmaceuticals Co., Inc. | Chief Executive Officer | 01/04/2014 |
E. Claiborne Robins Co., Inc.
 E. Claiborne Robins Co., Inc. Pharmaceuticals: GenericHealth Technology E. Claiborne Robins Co., Inc. engages in the development, manufacture and marketing of pharmaceutical products. It offers primary care products for treatment of allergy, headache and dermatitis. The company was founded in 1990 and is headquartered in Richmond, VA. | Chief Executive Officer | 01/04/2014 |
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Cameron Durrant
| Henley Management College | Masters Business Admin |
| Cardiff University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| MERCK & CO., INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| GSK PLC | Health Technology |
| ANAVEX LIFE SCIENCES CORP. | Health Technology |
| Entreprise privées | 18 |
|---|---|
Spherics, Inc.
 Spherics, Inc. Pharmaceuticals: MajorHealth Technology Spherics, Inc. develops pharmaceutical products to address the clinical needs of neurological disorders. Its technology is based on proprietary bio adhesive, biodegradable polymers, enhancers, and coatings. The company has established two distinct drug delivery systems: nano and macro spheres. Spherics was founded by Dr. Edith Mathiowitz in 1997 and is located in Mansfield, MA. | Health Technology |
Prism Pharmaceuticals, Inc.
 Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA. | Health Technology |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | Health Technology |
Striker Energy Corp.
 Striker Energy Corp. Other Metals/MineralsNon-Energy Minerals Striker Energy Corp. is an exploration stage company, which focuses on oil and natural gas exploration. It intends to search for oil and gas exploration opportunities. It focuses on oil and gas opportunities in emerging north american shale plays, such as the marcellus shale, the mowry shale, the utica shale and the bakken formation. The company was founded on March 18, 2005 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Health Technology |
Alcyone Therapeutics, Inc.
Alcyone Therapeutics, Inc. Medical SpecialtiesHealth Technology Alcyone Therapeutics, Inc. develops novel treatment modalities for difficult neurological conditions. The company was founded by Paramjith Anand, Adam S. Fleisher, Corey M. McCann, and William L. Olbricht in 2010 and is headquartered in Lowell, MA. | Health Technology |
PediaMed Pharmaceuticals, Inc.
 PediaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PediaMed Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company provides medicine in therapeutic categories, including respiratory and allergy, infectious disease, gastroenterology, and central nervous systems. The company was founded in 1999 and is headquartered in Florence, KY. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
E. Claiborne Robins Co., Inc.
E. Claiborne Robins Co., Inc. Pharmaceuticals: GenericHealth Technology E. Claiborne Robins Co., Inc. engages in the development, manufacture and marketing of pharmaceutical products. It offers primary care products for treatment of allergy, headache and dermatitis. The company was founded in 1990 and is headquartered in Richmond, VA. | Health Technology |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Consumer Services |
| PediatRx, Inc. /Old/ | Retail Trade |
Quint Media, Inc.
 Quint Media, Inc. Commercial Printing/FormsCommercial Services Quint Media, Inc. engages in digital, social media and entertainment business. It operates under the brand Exley. The company was founded on March 18, 2005 and is headquartered in West Palm Beach, FL. | Commercial Services |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Commercial Services |
Pressure Point, Inc.
Pressure Point, Inc. Medical/Nursing ServicesHealth Services Pressure Point, Inc. provides health care services. The private company is based in Central Point, OR. | Health Services |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Reliefband Technologies LLC
 Reliefband Technologies LLC Electronic Equipment/InstrumentsElectronic Technology Reliefband Technologies LLC designs and develops digital wearable devices that provides therapies for nausea, and morning sickness. The company was founded in 2015 and is headquartered in Horsham, PA. | Electronic Technology |
| Taran Pharma Ltd. | |
| ECR Pharmaceuticals Co., Inc. |
